Laboratory diagnosis plays one of the key roles in the diagnosis of many diseases, including
cardiovascular diseases (CVD). The methods underlying the in vitro study of many CVD …

Cardiovascular diseases (CVD) have one of the leading mortalities throughout the world; an
estimated 17.9 million people died from CVD in 2019, representing 32% of all global deaths …

comprehensive review of the published evidence for management of a given condition
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …

Background: Cardiac troponin (cTn) T and cTnI are considered cardiac specific and
equivalent in the diagnosis of acute myocardial infarction. Previous studies suggested rare …

Background: High-sensitivity cardiac troponin (hs-cTn) laboratory assays are used to rule
out myocardial infarction (MI) on presentation, but prolonged result turnaround times can …

Methods to improve the safety, accuracy and efficiency of assessment of patients with
suspected acute coronary symptoms have occupied decades of study and have supported …

In accordance with all the most recent international guidelines, the variation of circulating
levels of cardiac troponins I and T, measured with high-sensitivity methods (hs-cTnI and hs …

The term “single-sample rule-out” refers to the ability of very low concentrations of high-
sensitivity cardiac troponin (hs-cTn) on presentation to exclude acute myocardial infarction …

Apparently healthy children often complain of chest pain, especially after physical exercise.
Cardiac biomarker levels are often measured, but the clinical relevance of these assays in …

Background: The non–ST-segment–elevation myocardial infarction (NSTEMI) guidelines of
the European Society of Cardiology (ESC) recommend a 3h cardiac troponin determination …